Oruka Therapeutics, Inc. (ORKA)
NASDAQ: ORKA · Real-Time Price · USD
86.63
+4.54 (5.53%)
At close: Jun 25, 2026, 4:00 PM EDT
86.59
-0.04 (-0.05%)
Pre-market: Jun 26, 2026, 4:22 AM EDT
Oruka Therapeutics Market Cap
Oruka Therapeutics has a market cap or net worth of $5.22 billion as of June 26, 2026. Its market cap has increased by 958.00% in one year.
Market Cap
5.22B
Enterprise Value
4.73B
1-Year Change
958.00%
Ranking
Category
Stock Price
$86.63
Market Cap Chart
Since August 30, 2024, Oruka Therapeutics's market cap has increased from $849.32M to $5.22B, an increase of 515.18%. That is a compound annual growth rate of 171.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 25, 2026 | 5.22B | 256.09% |
| Dec 31, 2025 | 1.47B | 116.22% |
| Dec 31, 2024 | 678.62M | -20.10% |
| Aug 30, 2024 | 849.32M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Scholar Rock Holding | 5.89B |
| CG Oncology | 5.84B |
| Belite Bio | 5.79B |
| Legend Biotech | 5.45B |
| Xenon Pharmaceuticals | 5.30B |
| Ligand Pharmaceuticals | 5.25B |
| CRISPR Therapeutics AG | 5.24B |
| Travere Therapeutics | 5.12B |